|
Brief
Summary of Relevant Clinical Research Experience
Evaluation
of both the safety and efficacy of (usually) new chemical entities.
The clinical investigations have been predominantly (although
not exclusively) psychopharmacological studies, including but
not limited to ADD/ADHD, Alzheimer's disease, anxiety, craving
disorders, depression, insomnia, migraine headaches, mild cognitive
impairment, obesity, social anxiety disorder and vascular dementia.
Studies have ranged from phase II-IV, including both inpatient
and outpatient work, with enrollment ranging from five to 200.
Special studies have included pharmacokinetics, genomics, pharmacoeconomics
and quality of life assessments.
|